NEW YORK, NY / ACCESSWIRE / October 31, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM). Such investors are advised to contact
Better-than-expected Medicare Advantage membership aids HUM's third-quarter results.

Humana Inc. (HUM) Q3 2024 Earnings Call Transcript

01:09pm, Wednesday, 30'th Oct 2024
Humana Inc. (NYSE:HUM ) Q3 2024 Earnings Conference Call October 30, 2024 9:00 AM ET Company Participants Lisa Stoner - VP, IR James Rechtin - President and CEO Susan Diamond - CFO George Renaudin - P
Humana (NYSE:HUM), a for-profit American health insurance firm, reported a beat on the top and bottom lines for the third quarter and strengthened its full year profit guidance, sending its shares hig
While the top- and bottom-line numbers for Humana (HUM) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare
Humana (HUM) came out with quarterly earnings of $4.16 per share, beating the Zacks Consensus Estimate of $3.48 per share. This compares to earnings of $7.78 per share a year ago.
The health insurer still sees full-year adjusted per-share earnings of at least $16.

Humana beats quarterly profit estimates

06:37am, Wednesday, 30'th Oct 2024
Humana beat Wall Street estimates for third-quarter profit on Wednesday, helped by strength in its government-backed Medicare Advantage insurance business for older adults.
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended September 30, 2024 (3Q24) versus the qua
NEW YORK, NY / ACCESSWIRE / October 29, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM). Such investors are advised to contact
The health insurer's third-quarter report comes Wednesday. The numbers will show the growing problems with Medicare Advantage.
NEW YORK--(BUSINESS WIRE)---- $HUM #Humana--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Humana Inc. (“Humana” or “the Co
HUM's Q3 results are likely to suffer from decline in commercial fully-insured premiums and higher operating costs, partly offset by a well-performing Medicare business.
NEW YORK CITY, NY / ACCESSWIRE / October 29, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Humana Inc. ("Humana" or "the Company") (NYSE:HUM).
There has been speculation of a massive merger in the medical sector between two massive health insurers. Specifically, the rumor is The Cigna Group NYSE: CI is interested in acquiring Humana Inc. NYS
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE